secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seer, Inc. (SEER)
CIK:        0001726445
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001193125-26-204084
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seer appoints Anthony Bazarko as Chief Commercial Officer
---------------------------------------------------------

- Anthony Bazarko named CCO effective May 4, 2026; previously President & CEO of Biologos and CCO at Specific Diagnostics.
- Bazarko brings over 20 years of commercial leadership in life sciences, diagnostics, and biotech.
- He will lead Seer's Sales, Marketing, and Customer Experience to accelerate Proteograph Product Suite adoption.
- CEO Omid Farokhzad cites Bazarko's record of commercial strategy as key to next growth phase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726445/000119312526204084/0001193125-26-204084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726445/000119312526204084/ck0001726445-20260504.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-204084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer